Musculoskeletal Project 2
肌肉骨骼项目 2
基本信息
- 批准号:10231031
- 负责人:
- 金额:$ 38.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgingAmplifiersAnimal ModelAnti-Inflammatory AgentsAutoimmuneAutomobile DrivingB-LymphocytesBone DensityBone DiseasesBone ResorptionBone structureCD4 Positive T LymphocytesCaringCellsCenters of Research ExcellenceChronicClinical ResearchCommunitiesCross-Sectional StudiesCytokine ReceptorsDefectDeteriorationDevelopmentEpidemicEstrogensEtiologyEventFDA approvedFemaleFractureFrightFundingFutureGap JunctionsGrantHIVHIV InfectionsHIV antiretroviralHip FracturesHip region structureHumanImmuneImmune systemImmunocompromised HostImmunologic Deficiency SyndromesImmunologic FactorsImmunologicsIncidenceInflammationInflammatoryLactobacillus casei rhamnosusLigandsLymphocyteMediatingMenopauseModelingMolecularMusculoskeletalNF-kappa BOsteoclastsOsteogenesisOsteoporosisOvariectomyPHEMX genePharmaceutical PreparationsPhasePopulationPostmenopausal OsteoporosisPostmenopausePrevalenceProbioticsProductionRattusRecoveryReportingResearch DesignSex DifferencesSkeletal systemSkeletonSourceSpecialized CenterT cell reconstitutionT-LymphocyteTNF geneTRANCE proteinTestingTherapeuticTransgenic OrganismsTumor necrosis factor receptor 11bUnited States National Institutes of HealthViralWomanWomen&aposs Interagency HIV Studyadaptive immunityantiretroviral therapybonebone lossbone turnovercytokinefracture riskimmune functionimmune reconstitutioninflammatory bone lossinhibitor/antagonistmacrophagemenmouse modelosteoclastogenesisprotective effectreceptorskeletalsuccess
项目摘要
Project 2-Project Summary
HIV-infection causes bone loss that is paradoxically worsened by antiretroviral therapy (ART) leading to
significantly increased fracture rates in men and women. However, recent studies show that fracture incidence
is further exacerbated in HIV-infected women after the menopause, suggesting a collision between HIV/ART and
estrogen deficiency, aggravating skeletal deterioration. While the magnitude of bone loss may vary, all ART drug
classes cause bone loss and we have hypothesized that this is an indirect downstream effect of ART, driven by
immune-reconstitution and inflammatory events associated with the rekindling of adaptive immunity following T
cell reconstitution. We have demonstrated that an animal model of T cell reconstitution does indeed cause
significant inflammatory bone loss that closely mimics key features of ART-induced skeletal deterioration. In this
model, adaptive immune cells including lymphocytes and macrophages secrete the key osteoclastogenic
cytokines Receptor activator of NF-kB ligand (RANKL) and TNF which drives up basal bone resorption leading
to bone loss. Interestingly, postmenopausal osteoporosis, the archetypal bone disease of women, results from
estrogen decline after menopause that is also driven in part, by an inflammatory state characterized by B and T
cell production of RANKL and TNF by adaptive immune cells. Although the etiologies are different, because
bone loss in estrogen deficiency and in HIV/ART, both involve activation of adaptive immunity leading to the
development of chronic inflammatory states, we hypothesize that a collision between inflammatory bone loss
associated with HIV/ART may synergize with the inflammatory bone loss associated with estrogen deficiency.
Such events may account for exacerbated fracture in postmenopausal HIV-infected women and may portend a
looming epidemic of fracture in the rapidly aging female HIV community. Project 2 of this SCORE grant will study
whether HIV/ART- and estrogen deficiency-induced inflammatory events collide to additively or synergistically
augment inflammation and bone loss. We will employ animal models of ART- and estrogen deficiency-induced
inflammatory bone loss, and translational clinical studies in human HIV+ and HIV- women to quantify the
combined effects of HIV/ART and estrogen decline on bone structure and turnover in relation to adaptive immune
function and osteoclastogenesis. Our hypotheses, if validated, will significantly inform current understanding of
the collision between HIV/ART-induced skeletal decline with that of estrogen deficiency bone loss and the
underlying HIV-induced and estrogen deficiency induced immunological defects leading to bone loss and
establish whether these defects are additive or synergistic, or even diminished. This will have broad implications
for the future of HIV care especially as the population ages.
项目2项目摘要
HIV感染会导致骨质流失,抗逆转录病毒疗法(ART)矛盾地恶化
男性和女性的断裂率显着提高。但是,最近的研究表明骨折发生率
更年期后的艾滋病毒感染妇女进一步加剧,这表明艾滋病毒/艺术与
雌激素缺乏,加剧骨骼恶化。虽然骨质流失的大小可能有所不同,但所有艺术药物
课程会导致骨质流失,我们假设这是艺术的间接下游效应,由
与自适应免疫的重新燃烧时,免疫恢复原则和炎症事件
细胞重建。我们已经证明,T细胞重构的动物模型确实确实导致
明显的炎症性骨质流失非常模仿艺术引起的骨骼恶化的关键特征。在这个
模型,包括淋巴细胞和巨噬细胞在内的自适应免疫细胞分泌关键的破骨细胞。
NF-KB配体(RANKL)和TNF的细胞因子受体激活剂,它们驱动基础骨吸收领先
骨丢失。有趣的是,绝经后骨质疏松症,女性的原型骨疾病,由
绝经后的雌激素下降,这也部分由B和T为特征的炎症状态驱动
自适应免疫细胞对RANKL和TNF的细胞产生。尽管病因不同,因为
雌激素缺乏和艾滋病毒/ART中的骨质流失均涉及自适应免疫的激活导致
慢性炎症状态的发展,我们假设炎症性骨质流失之间的碰撞
与HIV/ART相关的可能与与雌激素缺乏相关的炎症性骨质流失协同作用。
这种事件可能会导致绝经后HIV感染的妇女加剧骨折,并可能预期
迅速衰老的女性艾滋病毒群落中骨折的迫在眉睫的流行。该分数的项目2将研究
HIV/ART和雌激素缺乏引起的炎症事件是否相撞或协同性地碰撞
增加炎症和骨质流失。我们将采用艺术和雌激素缺乏诱导的动物模型
炎症性骨质流失以及人类HIV+和HIV妇女的转化临床研究以量化
HIV/ART和雌激素下降对骨骼结构的综合作用与适应性免疫有关
功能和破骨细胞生成。我们的假设,如果得到验证,将大大为当前的理解提供了对
艾滋病毒/艺术引起的骨骼下降与雌激素缺乏骨质流失和
基本的HIV诱导和雌激素缺乏引起的免疫缺陷导致骨质流失和
确定这些缺陷是加性还是协同作用,甚至减少。这将具有广泛的影响
对于艾滋病毒护理的未来,尤其是随着人口年龄的增长。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mervyn Neale Weitzmann其他文献
Mervyn Neale Weitzmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mervyn Neale Weitzmann', 18)}}的其他基金
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): A stitch in time saves nine!
BCCMA:采取行动并抵抗对骨骼不利的条件的基础研究(骨折遏制):及时缝一针可以节省九针!
- 批准号:
10483595 - 财政年份:2022
- 资助金额:
$ 38.87万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease
外周与脑髓免疫在衰老和阿尔茨海默病认知能力下降中的作用
- 批准号:
10524957 - 财政年份:2022
- 资助金额:
$ 38.87万 - 项目类别:
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients
个性化麻醉大脑监测:为衰老、痴呆和阿尔茨海默病患者开发新型系统、传感器和算法
- 批准号:
10360566 - 财政年份:2021
- 资助金额:
$ 38.87万 - 项目类别:
Cost effective Electroencephalography sensor for monitoring sleep disruption in early stages of Alzheimer's disease
具有成本效益的脑电图传感器,用于监测阿尔茨海默病早期阶段的睡眠中断
- 批准号:
10478859 - 财政年份:2021
- 资助金额:
$ 38.87万 - 项目类别:
Cost effective Electroencephalography sensor for monitoring sleep disruption in early stages of Alzheimer's disease
具有成本效益的脑电图传感器,用于监测阿尔茨海默病早期阶段的睡眠中断
- 批准号:
10213321 - 财政年份:2021
- 资助金额:
$ 38.87万 - 项目类别:
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients
个性化麻醉大脑监测:为衰老、痴呆和阿尔茨海默病患者开发新型系统、传感器和算法
- 批准号:
10303200 - 财政年份:2021
- 资助金额:
$ 38.87万 - 项目类别: